Medicom Innovation Partner as:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Medicom Innovation Partner as - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C0145
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Medicom Innovation Partner a/s (Medicom), formerly Bang & Olufsen Medicom, a subsidiary of Phillips-Medisize Corp, is a medical device company that develops electronic-based drug delivery and connected health systems. The company offers services such as device strategy and direction, device feasibility and concept, device development, and pilot and low-volume production services. Its device feasibility and concept services provide fast forwarding services for device strategy into design concepts and prototypes. Medicom’s target therapy areas include injectables, inhalables and oral therapies. The company invests in technologies, competencies and processes in the areas of drug delivery devices and connected services. It has its presence in China, Denmark and the UK. Medicom is headquartered in Struer, Denmark.

Medicom Innovation Partner as – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Medicom Innovation Partner a/s, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Medicom Innovation Partner a/s, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Medicom Innovation Partner a/s, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Medicom Innovation Partner a/s, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Medicom Innovation Partner a/s, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Medicom Innovation Partner a/s, Medical Equipment, Deal Details 10
Private Equity 10
Maj Invest Equity Acquires Remaining 35% Stake in Bang & Olufsen Medicom 10
Partnerships 11
Bang & Olufsen Medicom Enters into Licensing Agreement with Pharma Company 11
Bang & Olufsen Medicom Enters Into Licensing Agreement With Pharma Company For Electronic Auto-Injector 12
Medicom Innovation Partner Enters into Co-Development Agreement with A Pharma Company for Electronic Drug Delivery System 13
Medicom Innovation Partner Enters into Co-Development Agreement with A Pharma Company 14
Bang & Olufsen Medicom Enters into Co-Development Agreement with Ascendis Pharma 15
Bang & Olufsen Medicom Enters into Co-Development Agreement with Boehringer Ingelheim 16
Bang & Olufsen Medicom Enters into Co-Development Agreement with Pharma Company 17
Bang & Olufsen Medicom Enters Into Co-Development Agreement With Pharma Company For Electronic Auto-Injector 18
Acquisition 19
Phillips-Medisize Acquires Medicom Innovation Partner 19
Medicom Innovation Partner a/s – Key Competitors 20
Medicom Innovation Partner a/s – Key Employees 21
Medicom Innovation Partner a/s – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Product News 23
Feb 01, 2017: Phillips-Medisize and Medicom Innovation Partner to Present at Drug Delivery Partnerships 2017 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Medicom Innovation Partner a/s, Medical Equipment, Key Facts 2
Medicom Innovation Partner a/s, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Medicom Innovation Partner a/s, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Medicom Innovation Partner a/s, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Medicom Innovation Partner a/s, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Medicom Innovation Partner a/s, Deals By Market, 2012 to YTD 2018 8
Medicom Innovation Partner a/s, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Maj Invest Equity Acquires Remaining 35% Stake in Bang & Olufsen Medicom 10
Bang & Olufsen Medicom Enters into Licensing Agreement with Pharma Company 11
Bang & Olufsen Medicom Enters Into Licensing Agreement With Pharma Company For Electronic Auto-Injector 12
Medicom Innovation Partner Enters into Co-Development Agreement with A Pharma Company for Electronic Drug Delivery System 13
Medicom Innovation Partner Enters into Co-Development Agreement with A Pharma Company 14
Bang & Olufsen Medicom Enters into Co-Development Agreement with Ascendis Pharma 15
Bang & Olufsen Medicom Enters into Co-Development Agreement with Boehringer Ingelheim 16
Bang & Olufsen Medicom Enters into Co-Development Agreement with Pharma Company 17
Bang & Olufsen Medicom Enters Into Co-Development Agreement With Pharma Company For Electronic Auto-Injector 18
Phillips-Medisize Acquires Medicom Innovation Partner 19
Medicom Innovation Partner a/s, Key Competitors 20
Medicom Innovation Partner a/s, Key Employees 21
Medicom Innovation Partner a/s, Other Locations 22
Medicom Innovation Partner a/s, Subsidiaries 22

List of Figures
Medicom Innovation Partner a/s, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Medicom Innovation Partner a/s, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Medicom Innovation Partner a/s, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Medicom Innovation Partner a/s, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Medicom Innovation Partner a/s, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Medicom Innovation Partner a/s, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Medicom Innovation Partner a/s, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Medicom Innovation Partner a/s, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Medicom Innovation Partner as:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • iRobot Corp (IRBT):企業の財務・戦略的SWOT分析
    iRobot Corp (IRBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • British Broadcasting Corporation:企業の戦略・SWOT・財務分析
    British Broadcasting Corporation - Strategy, SWOT and Corporate Finance Report Summary British Broadcasting Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Humanwell Healthcare (Group) Co Ltd (600079):製薬・医療:M&Aディール及び事業提携情報
    Summary Humanwell Healthcare (Group) Co Ltd (Humanwell), formerly Wuhan Humanwell Hi-Tech Industry Co Ltd is a pharmaceutical company that offers generic products. The company offers pharmaceutical, medical instrument and reproductive health care products and technologies. Its products include anest …
  • Bayer AG (BAYN):製薬・医療:M&Aディール及び事業提携情報
    Summary Bayer AG (Bayer) carries out the research, development, production and commercialization of products for human and animal health care, and agriculture. It provides medicines for cardiovascular diseases, women’s health, cancer, hematology, ophthalmology and other indications. The company's pr …
  • Sidney Kimmel Comprehensive Cancer Center-製薬・医療分野:企業M&A・提携分析
    Summary Sidney Kimmel Comprehensive Cancer Center (Sidney Kimmel) is a healthcare service provider that concentrates on diagnosis, treatment, and prevention of cancer. The center’s specialties include cancer diagnostic and treatment planning, blood and bone marrow cancers, cancer immunotherapy, brai …
  • Thor Industries, Inc.:企業の戦略・SWOT・財務分析
    Thor Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Thor Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • EMC Insurance Group Inc.:企業の戦略・SWOT・財務情報
    EMC Insurance Group Inc. - Strategy, SWOT and Corporate Finance Report Summary EMC Insurance Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • IDT Australia Ltd (IDT)-製薬・医療分野:企業M&A・提携分析
    Summary IDT Australia Ltd (IDT) is a contract manufacturing company that specializes in the development, scale-up and production of active pharmaceutical ingredients (APIs), microbiological and analytical testing, clinical trial research services and pharmacy services. The company also specializes i …
  • DTE Energy Co (DTE):企業の財務・戦略的SWOT分析
    DTE Energy Co (DTE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Adverum Biotechnologies Inc (ADVM):製薬・医療:M&Aディール及び事業提携情報
    Summary Adverum Biotechnologies Inc (Adverum), formerly Avalanche Biotechnologies Inc, is a clinical-stage gene therapy provider. The company’s product pipeline includes AVDM-053, ADVM-022 and AVA-311. Its products are used for treatment of antitrypsin deficiency, hereditary angioedema, wet age-rela …
  • Gene Techno Science Co Ltd (4584)-製薬・医療分野:企業M&A・提携分析
    Summary Gene Techno Science Co Ltd (GTS) is a developer and marketer of drug and antibodies for cancer, intractable diseases and rare diseases. The company develops biological and biosimilar products. Its biological pipeline products include GND-001 for immunological disease and oncology; GND-004, f …
  • Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ):製薬・医療:M&Aディール及び事業提携情報
    Summary Eckert & Ziegler Strahlen- und Medizintechnik AG (Eckert & Ziegler) is a medical device company that offers isotope technology products. The company offers radiation therapy, isotope and radio-pharma products. It provides radiation therapy products for Brachytherapy, a minimally invasive pro …
  • LongReach Group Limited:企業の戦略・SWOT・財務情報
    LongReach Group Limited - Strategy, SWOT and Corporate Finance Report Summary LongReach Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • MGB Biopharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary MGB Biopharma Ltd (MGB Biopharma) is a a biopharmaceutical company which develops novel class of anti-infectives using Minor Groove Binder (MGBs) compounds. Its lead drug candidate MGB-BP-3 in the field of antibacterial resistance is active against may Gram-positive bacteria. MGB Biopharma a …
  • Gradalis Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Gradalis Inc (Gradalis), formerly Murex Pharmaceuticals Inc, is a biopharmaceutical company that provides development and commercialization of therapies for the treatment of cancer. The company’s developmental pipeline comprises of candidates for various cancer indications which include ovar …
  • Hyundai Motor Co (005380):企業の財務・戦略的SWOT分析
    Hyundai Motor Co (005380) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • W. R. Grace & Co:企業の戦略・SWOT・財務分析
    W. R. Grace & Co - Strategy, SWOT and Corporate Finance Report Summary W. R. Grace & Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Singapore Press Holdings Ltd (T39):企業の財務・戦略的SWOT分析
    Singapore Press Holdings Ltd (T39) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • A.F. Blakemore & Son Ltd (Foodservice):企業の戦略・SWOT・財務情報
    A.F. Blakemore & Son Ltd (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary A.F. Blakemore & Son Ltd (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Arcus Biosciences Inc (RCUS):製薬・医療:M&Aディール及び事業提携情報
    Summary Arcus Biosciences Inc (Arcus Biosciences) is a clinical stage bio-pharmaceutical company. The company develops and commercializes cancer immunotherapies. Its product pipeline includes AB928, which is in phase 1/1b trial; AB122 is being developed for cancer patients, is in Phase 1 trial; AB15 …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆